Articles related to ALZHEIMER'S/DEMENTIA

Discover how racial and ethnic disparities in Alzheimer’s neuroimaging research could be limiting our understanding of the disease across diverse populations. Learn more about the urgent need for more inclusive research.

Discover how a study from USC reveals that the most common genetic cause of ALS and FTD may have its roots in embryonic development, offering new avenues for early diagnosis and treatment.

The recent FDA approval of brexpiprazole for Alzheimer’s dementia patients has ignited concerns among healthcare professionals. Physicians are urged to carefully consider the drug’s minimal efficacy and increased mortality risk in their treatment decisions.

The recent study underscores the limited eligibility for new monoclonal antibody treatments in early Alzheimer’s patients, emphasizing the need for more inclusive research. Explore the detailed findings to understand the implications for treatment availability in diverse populations.

Join this essential Expert Exchange webcast on Identifying and Assessing Agitation in Alzheimer’s Dementia. With a duration of just 30 minutes and offering 0.50 credits, this program provides a unique opportunity to enhance your clinical skills and understanding of this critical aspect of Alzheimer’s care.

Explore the recent meta-analysis that delves into the potential of cholinesterase inhibitors in treating delusions and hallucinations in dementia patients. The findings reveal significant but clinically insignificant effects, highlighting the need for further research and targeted treatments.